Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

S A Willavize

Showing results (11-20 of 13) with videos related to

Pageof 2
Sort By:
You have reached the last page of results.This site can display upto 13 results.
American Journal of Surgery|February 6, 1999
A double-blind, placebo-controlled, parallel group study of oral trovafloxacin on bowel microflora in healthy male volunteersC H van Nispen, A I Hoepelman, M Rozenberg-Arska, et al.
The Journal of Antimicrobial Chemotherapy|June 1, 1997
Pharmacokinetics and safety of trovafloxacin in healthy male volunteers following administration of single intravenous doses of the prodrug, alatrofloxacinJ Vincent, J Venitz, R Teng, et al.
European Journal of Clinical Pharmacology|July 29, 2008
Lack of a pharmacokinetic interaction between a new smoking cessation therapy, varenicline, and digoxin in adult smokersH M Faessel, A H Burstein, M D Troutman, et al.
Pageof 2

Showing results (11-20 of 13) with videos related to

Sort By:
Pageof 2
You have reached the last page of results.This site can display upto 13 results.
American Journal of Surgery|February 6, 1999
A double-blind, placebo-controlled, parallel group study of oral trovafloxacin on bowel microflora in healthy male volunteersC H van Nispen, A I Hoepelman, M Rozenberg-Arska, et al.
The Journal of Antimicrobial Chemotherapy|June 1, 1997
Pharmacokinetics and safety of trovafloxacin in healthy male volunteers following administration of single intravenous doses of the prodrug, alatrofloxacinJ Vincent, J Venitz, R Teng, et al.
European Journal of Clinical Pharmacology|July 29, 2008
Lack of a pharmacokinetic interaction between a new smoking cessation therapy, varenicline, and digoxin in adult smokersH M Faessel, A H Burstein, M D Troutman, et al.
Pageof 2